Summit Therapeutics Inc (SMMT)

15.68 -2.73%

Summit Therapeutics Inc (SMMT) is currently trading at $15.68. This represents a loss of 2.73% from the previous session. With a market capitalization of $12.21B, SMMT is a key component of the Health Care sector. Investors looking to trade SMMT should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade SMMT commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Summit Therapeutics Inc (SMMT) shows a bearish trend. Analysts are watching the 16.51 level closely.

Fundamentals
Mkt Cap12.21B
P/E Ratio0.0000
Volume1,525,551
Others Watching (By Market Cap)
NTRA
Natera Inc $211.83
+1.10% DXCM
DexCom Inc $73.07
-0.03% BIIB
Biogen Inc $190.73
-2.25% IQV
Iqvia Holdings $161.91
-1.80% RPRX
Royalty Pharma $45.15
-0.55%
60-Day Technical Chart
Advanced Charting

Need more indicators for SMMT? Use the world's #1 platform.

Open SMMT on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $16
Metric SMMT
-2.73% 		F
+1.62% 		HIMS
+2.33% 		CIFR
-2.98%
Price $15.68 $14.43 $15.82 $16.61
Mkt Cap $12.21B $57.57B $3.63B $6.61B
- View → View → View →
Latest Headlines
Summit Therapeutics posts $1.08B loss, FDA accepts lung cancer BLA Stock Titan • Feb 23, 2026 SMMT: Analyst Lowers Price Target to $30, Maintains Buy Rating | GuruFocus • Feb 24, 2026 Summit Therapeutics (SMMT) Valuation Check After Recent Share Price Pullback And Conflicting Model Signals Yahoo Finance • Jan 30, 2026 $SMMT stock is down 5% today. Here's what we see in our data. Quiver Quantitative • Jan 23, 2026 Assessing Summit Therapeutics (SMMT) Valuation After Ivonescimab FDA Filing And New GSK Trial Collaboration Sahm • Jan 14, 2026
● Gemini Agentic AI Analyst Insight for SMMT
Market Education
View All Articles →
External Research